EUGENE NYLE BUSH
Pharmacy in Green Oaks, IL

License number
Pennsylvania RP029413L
Category
Pharmacy
Type
Pharmacist
Address
Address 2
Green Oaks, IL 60048
Pennsylvania

Personal information

See more information about EUGENE NYLE BUSH at radaris.com
Name
Address
Phone
Eugene Bush
5318 N Isabell Ave, Peoria, IL 61614
(309) 868-0984
Eugene Bush
7949 Felton Rd, Prophetstown, IL 61277
Eugene Bush, age 57
816 Bedford Ln, Libertyville, IL 60048
(312) 933-0465
Eugene Bush
1401 Nectar Ave, E Saint Louis, IL 62205
(618) 558-5832
Eugene Bush
16182 Ridgewood Dr, Morrison, IL 61270
(815) 772-4636

Professional information

Eugene Bush Photo 1

Histamine-3 Receptor Ligands For Diabetes Conditions

US Patent:
2003013, Jul 17, 2003
Filed:
Jan 11, 2002
Appl. No.:
10/043848
Inventors:
Arthur Hancock - Libertyville IL, US
Eugene Bush - Libertyville IL, US
Marlon Cowart - Round Lake Beach IL, US
Peer Jacobson - Libertyville IL, US
Terry Opgenorth - Racine WI, US
Youssef Bennani - Shaker Heights OH, US
International Classification:
A61K031/55, A61K031/397, A61K031/541, A61K031/5377, A61K031/496, A61K031/454, A61K031/4025, A61K031/382, A61K031/353, A61K031/165
US Classification:
514/210200, 514/217080, 514/227800, 514/232500, 514/254010, 514/326000, 514/422000, 514/432000, 514/456000, 514/620000
Abstract:
The invention relates to a method of treating a diabetic condition by administering a therapeutically effective amount of a histamine-3 receptor antagonist, including benzofuran and benzopyran derivatives of formula (I), aminoalkoxybiphenylcarboxamide compounds of formula (III), and aminoetherbiphenyl compounds of formula (IV) as described herein.


Eugene Bush Photo 2

Histamine-3 Receptor Ligands For Diabetic Conditions

US Patent:
2005011, May 26, 2005
Filed:
Oct 6, 2004
Appl. No.:
10/959799
Inventors:
Arthur Hancock - Libertyville IL, US
Eugene Bush - Libertyville IL, US
Marlon Cowart - Round Lake Beach IL, US
Peer Jacobson - Libertyville IL, US
Terry Opgenorth - Racine WI, US
Youssef Bennani - Shaker Heights OH, US
International Classification:
A61K031/40, A61K031/366, A61K031/165
US Classification:
514408000, 514457000, 514620000
Abstract:
The invention relates to a method of treating a diabetic condition by administering a therapeutically effective amount of a histamine-3 receptor antagonist, including benzofuran and benzopyran derivatives of formula (I), aminoalkoxybiphenylcarboxamide compounds of formula (III), and aminoetherbiphenyl compounds of formula (IV) as described herein.


Eugene Bush Photo 3

Histamine-3 Receptor Ligands For Diabetic Conditions

US Patent:
2003015, Aug 14, 2003
Filed:
Dec 23, 2002
Appl. No.:
10/326546
Inventors:
Arthur Hancock - Libertyville IL, US
Eugene Bush - Libertyville IL, US
Marlon Cowart - Round Lake Beach IL, US
Peer Jacobson - Libertyville IL, US
Terry Opgenorth - Racine WI, US
Youssef Bennani - Shaker Heights OH, US
International Classification:
A61K031/53, A61K031/54, A61K031/495, A61K031/435, A61K031/537, A61K031/55
US Classification:
514/210200, 514/252010, 514/255050, 514/256000, 514/408000, 514/422000, 514/217120, 514/252120, 514/227500, 514/237800, 514/317000, 514/337000
Abstract:
The invention relates to a method of treating a diabetic condition by administering a therapeutically effective amount of a histamine-3 receptor antagonist, including benzofuran and benzopyran derivatives of formula (I), aminoalkoxybiphenylcarboxamide compounds of formula (III), and aminoetherbiphenyl compounds of formula (IV) as described herein.


Eugene Bush Photo 4

Combination And Use Of Drugs

US Patent:
2006027, Dec 7, 2006
Filed:
May 11, 2006
Appl. No.:
11/432782
Inventors:
Peer Jacobson - Libertyville IL, US
Michael Brune - Mundelein IL, US
Eugene Bush - Libertyville IL, US
Terry Opgenorth - Racine WI, US
Christine Collins - Skokie IL, US
Thomas von Geldern - Richmond IL, US
International Classification:
A61K 31/137
US Classification:
514649000
Abstract:
The present invention is directed to preferred pharmaceutical compositions comprising sibutramine and rimonabant and use of sibutramine and rimonabant to treat obesity and obesity related disorders in a patient.